Microsoft (MSFT) Stock Higher, Developing AI Cancer Treatment Technology

NEW YORK (TheStreet) — Shares of Microsoft  (MSFT)  were increasing in mid-morning trading on Tuesday as the technology giant is creating artificial intelligence (AI) technology that can help with cancer treatment.  The Redmond WA-based company’s project, called Hanover, processes medical information and helps predict which drugs and which combinations are most effective, Bloomberg reports.  Hanover will focus on finding combinations that treat acute myeloid leukemia, a type of cancer that’s recently experienced stagnant research growth. Targeted therapies have seen some success among cancer patients, but researchers note that a combination of targeted drugs could keep cancer from coming back, according to Bloomberg. Hanover could help identify what drug combinations are the most effective.  Hanover is based on machine learning technology, which several other competitors like IBM’s (IBM) Watson Oncology and Alphabet’s (GOOGL) Google unit are also harnessing. The technology…

Link to Full Article: Microsoft (MSFT) Stock Higher, Developing AI Cancer Treatment Technology

Pin It on Pinterest

Share This